Sarcoma  >>  crenolanib (ARO-002)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
crenolanib (ARO-002) / AROG
NCT02847429 / 2015-000287-34: Randomized Trial of Crenolanib in Subjects With D842V Mutated GIST

Active, not recruiting
3
120
Europe, US
Crenolanib, Crenolanib Besylate, Placebo
Arog Pharmaceuticals, Inc., Centre Leon Berard, Fox Chase Cancer Center
GIST With D842V Mutated PDGFRA Gene
08/21
08/21

Download Options